Stories from MedEsthetics

Business Education for Medical Practitioners
Visit us at medestheticsmagazine.com
Thursday, November 16, 2017 - 12:37
China Regenerative Medicine International (CRMI) has acquired Obagi Medical Products from Valeant Pharmaceuticals for $190 million in cash. CRMI, which operates seven production plants in mainland China and Hong Kong, specializes in the research, development and commercialization of innovative bio-medical, healthcare products and medical techniques. In a press release, the company noted that this acquisition will help pave the way for future development of its cosmeceutical business in both the U.S. and international markets.
https://www.medestheticsmag.com/crmi-acquires-obagi-medical
Thursday, November 16, 2017 - 12:35
Obesity is associated with an increased risk of rosacea in women, according to a new study published in the December 2017 issue of the Journal of the American Academy of Dermatology. Authors Suyun Li, PhD, et al, identified 5,249 cases of rosacea diagnosed from 1991-2005 among 89,886 women who participated in the Nurses’ Health Study II. They found significant correlation between rosacea risk and higher body mass index (≥35), particularly among those who had gained weight after age 18.
https://www.medestheticsmag.com/obesity-and-waist-circumference-risk-factors-rosacea
Thursday, November 16, 2017 - 12:33
Kate Ricciardi has been hired as the new marketing project manager for skincare manufacturer Skinprint. Ricciardi is a recent graduate of Hofstra University. She received her Bachelor of Arts degree in Broadcast Journalism with a minor in Public Relations and worked as an intern with CBS News and the International Academy of Television Arts and Sciences. In addition to developing and executing all e-commerce projects, Ricciardi will be responsible for the company’s website (skinprint.com) and all social media campaigns.
https://www.medestheticsmag.com/skinprint-names-kate-ricciardi-new-marketing-project-manager
Thursday, November 16, 2017 - 12:30
A new neurotoxin with a fast onset of action and shorter duration of effect is in development for aesthetics and pain relief.By Inga HansenWhile the aesthetics industry has been focused on new botulinum toxin products and dosing strategies geared toward increasing longevity of results, a new company Bonti has been developing EB-001, a serotype E botulinum toxin that moves in the opposite direction. “This molecule is very similar to the existing botulinum toxin serotype A products in terms of mechanism of action, however, it has two differentiating factors.
https://www.medestheticsmag.com/no-pain-swift-gains
Thursday, November 9, 2017 - 13:03
A new standard classification system of rosacea, developed by a consensus committee from the National Rosacea Society (NRS) and review panel of 28 rosacea experts worldwide, has been published online in the Journal of the American Academy of Dermatology (November 1, 2017).
https://www.medestheticsmag.com/new-standard-classification-rosacea-published
Thursday, November 9, 2017 - 13:01
A new study, published in the Journal of Drugs in Dermatology (November 2017), found that pulsed dye lasers (PDL) and the MaxG Optimized Light Handpiece (500-670nm and 870-1200nm) offer the best outcomes for patients with facial telangiectasia. Lin Gao, MD, et al, of the Xijing Hospital department of dermatology in Xi’an, China, performed a retrospective analysis of 416 patients with facial telangiectasia who were treated by PDL or IPLs in their department from August 2012 to March 2015.
https://www.medestheticsmag.com/best-wavelengths-treatment-facial-telangiectasia
Thursday, November 9, 2017 - 12:58
Operation Smile is celebrating its 35th anniversary with new global initiatives that will help the organization reach even more children in need. William “Bill” P. Magee Jr., MD, and his wife Kathy founded Operation Smile in 1982 following a medical mission to the Philippines. Thirty-five years later it has provided hundreds of thousands of surgeries to children with cleft lip, cleft palate and other facial deformities via 160 annual medical missions at 29 international care centers.
https://www.medestheticsmag.com/operation-smile-celebrates-35-years
Thursday, November 9, 2017 - 12:55
How to reduce the risk of impaired employees.By Phillip M. PerryAn employee who is misusing drugs can threaten your bottom line in many ways: higher absenteeism; lower productivity; increased losses due to theft; and costly accidents that spark lawsuits. The problem of illicit drug use has become more prevalent in recent years due to the escalation of opioid addiction and the legalization of marijuana on the state level.
https://www.medestheticsmag.com/practice-management-workplace-drug-use
Thursday, November 2, 2017 - 12:21
On-the-horizon topicals and light-based therapies may offer increasingly effective outcomes for acne sufferers.By Shelley Moench-Kelly, MBAAcne is the most common skin disorder in the U.S., yet a cure remains elusive. Current treatments, including topical medications that decrease sebum or kill bacteria; oral medications such as birth control pills, antibiotics or isotretinoin; and lasers or light-based treatments, can offer temporary relief. But concerns about antibiotic resistance, combined with the serious risks—and associated regulations—of isotretinoin, are driving the development of new...
https://www.medestheticsmag.com/banishing-blemishes
Thursday, November 2, 2017 - 12:11
Laser manufacturer Sciton has entered into a strategic partnership with Michelson Diagnostics, Ltd. (MDL), maker of the VivoSight OCT (Optical Coherence Tomography), to develop OCT image-guided laser applications for its devices.
https://www.medestheticsmag.com/sciton-partners-michelson-develop-image-guided-laser-applications
Thursday, November 2, 2017 - 12:09
Three researchers have been awarded grants of $25,000 each by the National Rosacea Society (NRS) as part of the organization’s research grants program. The program supports research that may increase the medical community’s knowledge and understanding of the causes of rosacea in order to improve care and prevention and find a potential cure for the common skin disease. The grant recipients are:
https://www.medestheticsmag.com/researchers-awarded-nrs-grants-rosacea-research
Thursday, November 2, 2017 - 12:05
William H. Truswell, MD, FACS, is the new president of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). He took office on October 28 and will serve for one year. Over the past four decades, Dr. Truswell has performed more than 30,000 head and neck reconstruction and cosmetic facial surgeries. He is board certified by the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology.
https://www.medestheticsmag.com/truswell-elected-president-aafprs
Wednesday, November 1, 2017 - 11:44
FEATURES On the horizon acne treatments »Banishing Blemishes
https://www.medestheticsmag.com/novemberdecember-2017
Thursday, October 26, 2017 - 12:08
Considering adding retail products to your practice? Here’s what you need to know about product selection, marketing and managing sales.By Karen AppoldSelling skincare and other products that appeal to your patient base can be an additional revenue stream for your medspa or practice. But for more money to flow in, you’ll need to sell quality merchandise, display products attractively and properly promote them. Michael Lin, MD, offers products that complement the procedures he provides and the medical conditions that he treats at his practice, Advanced Dermatology and Skin Cancer Institute,...
https://www.medestheticsmag.com/succeeding-retail
Thursday, October 26, 2017 - 11:59
BTL Aesthetics has released long-term data on patients who underwent treatment with the company’s noninvasive, radiofrequency energy-based Vanquish device for body contouring. Thirteen individuals who were part of a one-month follow-up study published in the Journal of Drugs and Dermatology came back four years later to determine if their circumference reductions had sustained long-term. The patients preserved an average 75.2% of the original body contouring effect four years post treatment.
https://www.medestheticsmag.com/long-term-data-vanquish-noninvasive-fat-reduction-treatments
Thursday, October 26, 2017 - 11:56
Patients with frontal fibrosing alopecia (FFA) who were treated with either oral isotretinoin or acitretin experienced a significant slowing in the progression of the diseases compared to patients treated with finasteride. Researchers Adriana Rakowska, MD, PhD, et al, performed a retrospective analysis of 54 female patients with FFA who were treated with 20mg/day of oral isotretinoin (29 patients), 20mg/day of acitretin (11 patients) or 5mg/day of oral finasteride (14 patients) between 2007 and 2017.
https://www.medestheticsmag.com/oral-retinoids-effective-frontal-fibrosing-alopecia
Thursday, October 26, 2017 - 11:53
eRelevance Corporation, a customer marketing automation service for small- to medium-size businesses, has announced the appointment of Chris Greta as its first chief creative officer. Greta brings more than 35 years of experience in the advertising, branding and creative industries to the position. He founded The Ad Ranch, a full-service agency, which he sold to Catapult Systems. He later formed Slingrock.com, an award-winning interactive, branding, design and marketing agency.
https://www.medestheticsmag.com/greta-named-chief-creative-officer-erelevance
Thursday, October 19, 2017 - 14:17
The 532nm/1,064nm Picoway Resolve picosecond holographic fractional handpiece (Syneron-Candela) improved acne scarring by an average of 28%, according to the results of a study published in Lasers in Surgery and Medicine (November 2017). Eric Bernstein, MD, et al, treated 31 subjects with either rolling or boxcar-type acne scars using either the 532nm wavelength or 1,064nm. Of the 27 subjects who completed the study, 19 were treated with 1,064nm and eight with 532nm. All underwent four monthly treatments.
http://medestheticsmag.com/picoway-resolve-effective-acne-scars

Pages

Advertisement - Box 1

Advertisement - Box 2

Advertisement - Box 3

Advertisement - Box 4

Advertisement - Box 5

Advertisement - Box 6